ChiefsPlanet Mobile
Page 32 of 32
« First < 222829303132
Washington DC and The Holy Land>The geopolitical fight to minimize Hydroxychloroquine
Taco John 02:36 AM 04-09-2020

The #CDC removed several paragraphs of information about #Hydroxychloroquine from its website, including recommended dosing information.

The @CDCgov didnít immediately respond to a request for comment.

— The Epoch Times (@EpochTimes) April 9, 2020

Pogue 12:55 AM 06-30-2020

A tale of two drugs...

Remdesivir & HCQ both show promise for COVID-19

HCQ is discredited w/ fraudulent data, FDA warnings & overdoses

Remdesivir is praised w/ tightly guarded data by the NIH and a task force of Gilead investors/employees

HCQ: Under $10
Remdesivir: Over $3000

— James Todaro, MD (@JamesTodaroMD) June 29, 2020

Ninerfan11 01:56 AM 06-30-2020
lol, looks like he might end up being right :-) :-).
Hammock Parties 08:37 AM 07-03-2020

A surprising new study found that the controversial antimalarial drug hydroxychloroquine helped Covid-19 patients better survive in the hospital.

— CNN (@CNN) July 3, 2020

JohnnyHammersticks 09:42 AM 07-03-2020
So it now appears that Hydroxychloroquine cuts the death rate for hospitalized Kung Flu patients IN HALF. Every life matters, right Libtards? Even one is too many, right Libtards? Unless it comes to the lives saved by Hydroxychloroquine, those people can get fucked, right Libtards?

Libtards/Trump-haters: "But but but but.....Orange Man Baaaaaaaaaaaaad!!!!!!"

Fauci the Fraud should be fired IMMEDIATELY.

Treatment with Hydroxychloroquine Cut Death Rate Significantly in COVID-19 Patients, Henry Ford Health System Study Shows
July 02, 2020

DETROIT – Treatment with hydroxychloroquine cut the death rate significantly in sick patients hospitalized with COVID-19 – and without heart-related side-effects, according to a new study published by Henry Ford Health System.

In a large-scale retrospective analysis of 2,541 patients hospitalized between March 10 and May 2, 2020 across the system’s six hospitals, the study found 13% of those treated with hydroxychloroquine alone died compared to 26.4% not treated with hydroxychloroquine. None of the patients had documented serious heart abnormalities; however, patients were monitored for a heart condition routinely pointed to as a reason to avoid the drug as a treatment for COVID-19.

The study was published today in the International Journal of Infectious Diseases, the peer-reviewed, open-access online publication of the International Society of Infectious Diseases (

Patients treated with hydroxychloroquine at Henry Ford met specific protocol criteria as outlined by the hospital system’s Division of Infectious Diseases. The vast majority received the drug soon after admission; 82% within 24 hours and 91% within 48 hours of admission. All patients in the study were 18 or over with a median age of 64 years; 51% were men and 56% African American.

The findings have been highly analyzed and peer-reviewed,” said Dr. Marcus Zervos, division head of Infectious Disease for Henry Ford Health System, who co-authored the study with Henry Ford epidemiologist Dr. Samia Arshad. “We attribute our findings that differ from other studies to early treatment, and part of a combination of interventions that were done in supportive care of patients, including careful cardiac monitoring. Our dosing also differed from other studies not showing a benefit of the drug. And other studies are either not peer reviewed, have limited numbers of patients, different patient populations or other differences from our patients.”

Zervos said the potential for a surge in the fall or sooner, and infections continuing worldwide, show an urgency to identifying inexpensive and effective therapies and preventions.

“We’re glad to add to the scientific knowledge base on the role and how best to use therapies as we work around the world to provide insight,” he said. “Considered in the context of current studies on the use of hydroxychloroquine for COVID-19, our results suggest that the drug may have an important role to play in reducing COVID-19 mortality.”

The study also found those treated with azithromycin alone or a combination of hydroxychloroquine and azithromycin also fared slightly better than those not treated with the drugs, according to the Henry Ford data. The analysis found 22.4% of those treated only with azithromycin died, and 20.1% treated with a combination of azithromycin and hydroxychloroquine died, compared to 26.4% of patients dying who were not treated with either medication.

Our analysis shows that using hydroxychloroquine helped saves lives,” said neurosurgeon Dr. Steven Kalkanis, CEO, Henry Ford Medical Group and Senior Vice President and Chief Academic Officer of Henry Ford Health System. “As doctors and scientists, we look to the data for insight. And the data here is clear that there was benefit to using the drug as a treatment for sick, hospitalized patients.”

LiveSteam 10:35 AM 07-03-2020
Originally Posted by Lex Luthor:
Meh. I can see that he has been banned. I don't presume to know why.

All I know is that the post I quoted was solid. Taco John has been talking out his ass about Hydroxichloroquine, and he dosn't know shit about it.

All he knows is that Trump recommended it, and that's good enough for him.
ChiefsCountry 01:03 PM 07-03-2020
Hmm what I had posted earlier
Page 32 of 32
« First < 222829303132